Membranoproliferative Glomerulonephritis (MPGN) in PEDSnet
Study Dates
Last Modified
Tags
Publisher
Abstract
Study to identify and conduct phenotypic characterization of children with C3G and IC-MPGN in PEDSnet using data science and chart review methods. The long-term goal of this work is to perform a large multi-institutional natural history study, compare clinical outcomes in C3G and IC-MPGN, and identify predictors of disease response or progression.
Affiliation(s)
Funder(s)
Provenance
Description
C3 Glomerulopathy (C3G) and Immune Complex-associated Membranoproliferative Glomerulonephritis (IC-MPGN) are diseases with distinct underlying pathophysiologic mechanisms. C3G is widely recognized to be due to defective regulation of the alternative complement pathway, whereas IC-MPGN is associated with classical complement pathway activation by circulating or in situ immune complex formation. Historically, however, these diseases were categorized as various subtypes of MPGN by their histological appearance by electron microscopy, which led to uncertainty as to the precise nature of their disease biology, as well as optimal treatment strategies. The literature describing the clinical characteristics, treatment response, and outcomes of patients with C3G and IC-MPGN are largely based on small retrospective studies, and primarily in adults. Extraction and rigorous phenotyping of C3G and IC-MPGN patients from a large multi-institutional data resource offers the opportunity to more fully characterize the natural history of C3G and IC-MPGN in children, as well as identify predictors of disease response to therapeutic interventions (both complement-targeted and immunosuppressive therapies).
Hypothesis
The purpose of this study is to identify and conduct phenotypic characterization of children with C3G and IC-MPGN in PEDSnet using data science and chart review methods. The long-term goal of this work is to perform a large multi-institutional natural history study, compare clinical outcomes in C3G and IC-MPGN, and identify predictors of disease response or progression. It is hypothesized that among pediatric patients with C3G and IC- will be identifiable subset(s) of patients who have optimal response to immunosuppression regimens and/or complement-targeted therapies. Patient sub-sets will be characterized by and histological, immunological, and clinical characteristics.
Cohort Description
Patients identified by the GLEAN algorithm with a diagnosis of MPGN.
Development Code
Vocabulary
Clinical Subjects Headings
Related Publications
Denburg MR, Razzaghi H, Bailey C, Soranno DE, et al. December 2019. “Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.” JASN 30(12):p 2427-2435. DOI: 10.1681/ASN.2019040365
Creative Commons license
